Paxil side effects: paxil lawyers and attorneys, paxil class action
Paxil side effects. .0% 2.4% 0.9% Asthenia 4.9% 3.0% 1.4% Somnolence* 4.3% 1.8% 0.3% Insomnia 2.3% 1.5% 0.0% Concentration Impaired* 2.0% 0.6% 0.3% Dry mouth* 2.0% 0.6% 0.3% Dizziness* 1.7% 0.6% 0.6% Decreased Appetite* 1.4% 0.6% 0.0% Sweating* 1.4% 0.0% 0.3% Tremor* 1.4% 0.3% 0.0% Yawn* 1.1% 0.0% 0.0% Diarrhea 0.9% 1.2% 0.0% *Events considered to be dose dependent are defined as events having an incidence rate with 25 mg of PAXIL CR that was at least twice that with 12.5 mg of PAXIL CR (as well as the placebo group). Commonly Observed Adverse Events Major Depressive Disorder: The most commonly observed adverse events associated with the use of PAXIL CR in a pool of 2 trials (incidence of 5.0% or greater and incidence for PAXIL CR at least twice that for placebo, derived from Table 1) were: Abnormal ejaculation, abnormal vision, constipation, decreased libido, diarrhea, dizziness, female genital disorders, nausea, somnolence, sweating, trauma, tremor, and yawning. Using the same criteria, the adverse even
 |
|
Paxil side effects lawsuit | paxil attorney, lawyer
Ts associated with the use of PAXIL CR in a study of elderly patients with major depressive disorder were: Abnormal ejaculation, constipation, decreased appetite, dry mouth, impotence, infection, libido decreased, sweating, and tremor. Panic Disorder: In the pool of panic disorder studies, the adverse events meeting these criteria were: Abnormal ejaculation, somnolence, impotence, libido decreased, tremor, sweating, and female genital disorders (generally anorgasmia or difficulty achieving orgasm). Social Anxiety Disorder: In the social anxiety disorder study, the adverse events meeting these criteria were: Nausea, asthenia, abnormal ejaculation, sweating, somnolence, impotence, insomnia, and libido decreased. Premenstrual Dysphoric Disorder: The most commonly observed adverse events associated with the use of PAXIL CR either during continuous dosing or luteal phase dosing (incidence of 5% or greater and incidence for PAXIL CR at least twice that for placebo, derived from Table 5) were
|